4.5 Article

Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of Staphylococcus sciuri into the pancreas

Journal

INTERNATIONAL IMMUNOLOGY
Volume 34, Issue 12, Pages 621-634

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxac039

Keywords

autoimmune pancreatitis; autoimmune sialadenitis; intestinal barrier; plasmacytoid dendritic cells; Staphylococcus sciuri

Categories

Funding

  1. Japan Society for the Promotion of Science [21K15987, 22K08090, 22K07996]
  2. Takeda Science Foundation
  3. Yakult BioScience Foundation
  4. SENSHIN Medical Research Foundation
  5. 2022 Kindai University Research Enhancement Grant [KD2208]
  6. Japan Agency for Medical Research and Development (AMED) for Research on Intractable Diseases

Ask authors/readers for more resources

Intestinal barrier dysfunction exacerbates the development of autoimmune pancreatitis (AIP), possibly through the activation of plasmacytoid dendritic cells and the translocation of Staphylococcus sciuri.
Autoimmune pancreatitis (AIP) and IgG4-related disease (IgG4-RD) are new disease entities characterized by enhanced IgG4 antibody responses and involvement of multiple organs, including the pancreas and salivary glands. Although the immunopathogenesis of AIP and IgG4-RD is poorly understood, we previously reported that intestinal dysbiosis mediates experimental AIP through the activation of IFN-alpha- and IL-33-producing plasmacytoid dendritic cells (pDCs). Because intestinal dysbiosis is linked to intestinal barrier dysfunction, we explored whether the latter affects the development of AIP and autoimmune sialadenitis in MRL/MpJ mice treated with repeated injections of polyinosinic-polycytidylic acid [poly (I:C)]. Epithelial barrier disruption was induced by the administration of dextran sodium sulfate (DSS) in the drinking water. Mice co-treated with poly (I:C) and DSS, but not those treated with either agent alone, developed severe AIP, but not autoimmune sialadenitis, which was accompanied by the increased accumulation of IFN-alpha- and IL-33-producing pDCs. Sequencing of 16S ribosomal RNA revealed that Staphylococcus sciuri translocation from the gut to the pancreas was preferentially observed in mice with severe AIP co-treated with DSS and poly (I:C). The degree of experimental AIP, but not of autoimmune sialadenitis, was greater in germ-free mice mono-colonized with S. sciuri and treated with poly (I:C) than in germ-free mice treated with poly (I:C) alone, which was accompanied by the increased accumulation of IFN-alpha- and IL-33-producing pDCs. Taken together, these data suggest that intestinal barrier dysfunction exacerbates AIP through the activation of pDCs and translocation of S. sciuri into the pancreas.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available